1. Home
  2. RGEN vs FLR Comparison

RGEN vs FLR Comparison

Compare RGEN & FLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RGEN
  • FLR
  • Stock Information
  • Founded
  • RGEN 1981
  • FLR 1912
  • Country
  • RGEN United States
  • FLR United States
  • Employees
  • RGEN N/A
  • FLR N/A
  • Industry
  • RGEN Medical/Dental Instruments
  • FLR Military/Government/Technical
  • Sector
  • RGEN Health Care
  • FLR Industrials
  • Exchange
  • RGEN Nasdaq
  • FLR Nasdaq
  • Market Cap
  • RGEN 8.0B
  • FLR 8.5B
  • IPO Year
  • RGEN N/A
  • FLR N/A
  • Fundamental
  • Price
  • RGEN $127.47
  • FLR $52.90
  • Analyst Decision
  • RGEN Buy
  • FLR Strong Buy
  • Analyst Count
  • RGEN 12
  • FLR 7
  • Target Price
  • RGEN $170.40
  • FLR $49.14
  • AVG Volume (30 Days)
  • RGEN 694.0K
  • FLR 4.7M
  • Earning Date
  • RGEN 07-29-2025
  • FLR 08-01-2025
  • Dividend Yield
  • RGEN N/A
  • FLR N/A
  • EPS Growth
  • RGEN N/A
  • FLR 563.49
  • EPS
  • RGEN N/A
  • FLR 10.64
  • Revenue
  • RGEN $650,429,000.00
  • FLR $16,563,000,000.00
  • Revenue This Year
  • RGEN $13.93
  • FLR $10.92
  • Revenue Next Year
  • RGEN $14.35
  • FLR $6.29
  • P/E Ratio
  • RGEN N/A
  • FLR $4.96
  • Revenue Growth
  • RGEN 4.88
  • FLR 7.16
  • 52 Week Low
  • RGEN $102.97
  • FLR $29.20
  • 52 Week High
  • RGEN $182.52
  • FLR $60.10
  • Technical
  • Relative Strength Index (RSI)
  • RGEN 54.11
  • FLR 68.51
  • Support Level
  • RGEN $121.44
  • FLR $49.57
  • Resistance Level
  • RGEN $131.43
  • FLR $51.91
  • Average True Range (ATR)
  • RGEN 4.47
  • FLR 1.62
  • MACD
  • RGEN 0.61
  • FLR -0.14
  • Stochastic Oscillator
  • RGEN 74.57
  • FLR 97.44

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

About FLR Fluor Corporation

Fluor is one of the largest global providers of engineering, procurement, construction, fabrication, operations, and maintenance services. The firm serves a wide range of end markets, including oil and gas, chemicals, mining, metals, and transportation. The company's business is organized into three core segments: urban solutions, mission solutions, and energy solutions. Fluor generated $16.3 billion in revenue in 2024.

Share on Social Networks: